Professional Bio
Adetola Kassim, MBBS, Professor of Medicine in the Division of Hematology and Oncology, Department of Medicine at Vanderbilt University Medical Center, treats patient care not merely as a profession, but as a humanitarian and global health mission.
He is a clinical researcher in hematology and stem cell transplant and cellular therapy (SCT), focused on advancing the care and treatment outcomes for adults with sckle cell disease (SCD). SCT is a curative modality in the management of various benign and malignant hematologic disorders.
Dr. Kassim is currently exploring the use of a non-myeloablative haploidentical Bone Marrow Transplant (haploBMT) as a curative modality for patients with severe SCD. He established a multi-center collaborative group in 2013, resulting in improved outcomes and increased donor options allowing for the extension this novel curative therapy to more eligible patients with SCD in the United States and worldwide. The promising results from this pilot phase II trial have resulted in a National NHLBI BMT-Clinical Trial Network supported protocol in 2017 on haploBMT in SCD.
He is also a co-investigator of 2-NINDS funded clinical trials (SPIN and SPRING) on stroke prevention in children with sickle cell anemia in sub-Saharan Africa. SPIN is the first NIH-sponsored clinical trial on SCD in Africa, where the disease is most prevalent. Through these trials, we have been able to successfully build infrastructure and capacity of the research team in Kano, Nigeria.
Relevant Links
Publications
Education
MBBS - University of Lagos, 1988
Internship - Lagos State University, 1989
Residency - Mount Sinai School of Medicine, 1995
Fellowship - Sloan Kettering Cancer Center, 1998
Fellowship - Hem/Onc - Yeshiva University, 1998
Fellowship - Yeshiva University, 2000
Fellowship - Bone Marrow Transplant - Johns Hopkins University, 2001
Contact
Email
Kimryn.Rathmell@Vumc.Org
Address
777 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232-6307